Broderick Brian C Danaher Corp Transaction History

Broderick Brian C

  • $470 Million
  • Q3 2024

A detailed history of Broderick Brian C transactions in Danaher Corp stock. As of the latest transaction made, Broderick Brian C holds 62,410 shares of DHR stock, worth $14.4 Million. This represents 3.69% of its overall portfolio holdings.

Number of Shares
62,410
Previous 62,328 0.13%
Holding current value
$14.4 Million
Previous $15.6 Million 11.41%
% of portfolio
3.69%
Previous 3.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$239.25 - $280.76 $19,618 - $23,022
82 Added 0.13%
62,410 $17.3 Million
Q2 2024

Aug 12, 2024
BUY
$235.51 - $267.98 $24,493 - $27,869
104 Added 0.17%
62,328 $15.6 Million
Q1 2024

May 03, 2024
BUY
$224.58 - $256.19 $591,319 - $674,548
2,633 Added 4.42%
62,224 $15.5 Million
Q4 2023

Feb 13, 2024
BUY
$185.1 - $233.13 $527,535 - $664,420
2,850 Added 5.02%
59,591 $13.8 Million
Q3 2023

Nov 14, 2023
BUY
$233.08 - $265.59 $113,976 - $129,873
489 Added 0.87%
56,741 $14.1 Million
Q2 2023

Aug 11, 2023
BUY
$224.99 - $256.14 $5,849 - $6,659
26 Added 0.05%
56,252 $13.5 Million
Q1 2023

May 10, 2023
BUY
$239.75 - $277.0 $33,804 - $39,057
141 Added 0.25%
56,226 $14.2 Million
Q4 2022

Feb 09, 2023
SELL
$241.42 - $282.29 $412,586 - $482,433
-1,709 Reduced 2.96%
56,085 $14.9 Million
Q3 2022

Nov 08, 2022
SELL
$247.06 - $1507.4 $13,341 - $81,399
-54 Reduced 0.09%
57,794 $14.9 Million
Q2 2022

Jul 19, 2022
SELL
$237.11 - $299.66 $30,112 - $38,056
-127 Reduced 0.22%
57,848 $14.7 Million
Q1 2022

May 17, 2022
BUY
$257.27 - $315.76 $48,366 - $59,362
188 Added 0.33%
57,975 $17 Million
Q4 2021

Feb 08, 2022
SELL
$292.08 - $329.01 $618,333 - $696,514
-2,117 Reduced 3.53%
57,787 $19 Million
Q3 2021

Nov 10, 2021
SELL
$272.21 - $332.43 $524,548 - $640,592
-1,927 Reduced 3.12%
59,904 $18.2 Million
Q2 2021

Aug 09, 2021
SELL
$225.08 - $271.69 $322,989 - $389,875
-1,435 Reduced 2.27%
61,831 $16.6 Million
Q1 2021

May 17, 2021
SELL
$212.38 - $245.9 $113,410 - $131,310
-534 Reduced 0.84%
63,266 $14.2 Million
Q4 2020

Feb 16, 2021
SELL
$212.5 - $245.46 $282,837 - $326,707
-1,331 Reduced 2.04%
63,800 $14.2 Million
Q3 2020

Oct 28, 2020
SELL
$177.16 - $215.33 $239,874 - $291,556
-1,354 Reduced 2.04%
65,131 $14 Million
Q2 2020

Jul 28, 2020
SELL
$128.7 - $176.83 $100,772 - $138,457
-783 Reduced 1.16%
66,485 $11.8 Million
Q1 2020

May 07, 2020
SELL
$121.39 - $169.05 $31,925 - $44,460
-263 Reduced 0.39%
67,268 $9.31 Million
Q4 2019

Jan 15, 2020
SELL
$133.47 - $153.48 $55,923 - $64,308
-419 Reduced 0.62%
67,531 $10.4 Million
Q3 2019

Nov 04, 2019
SELL
$135.4 - $146.47 $116,714 - $126,257
-862 Reduced 1.25%
67,950 $9.81 Million
Q2 2019

Jul 24, 2019
SELL
$124.88 - $143.73 $26,349 - $30,327
-211 Reduced 0.31%
68,812 $9.84 Million
Q1 2019

Apr 29, 2019
SELL
$97.62 - $132.29 $34,167 - $46,301
-350 Reduced 0.5%
69,023 $9.11 Million
Q4 2018

Jan 24, 2019
BUY
$94.85 - $109.54 $3,794 - $4,381
40 Added 0.06%
69,373 $7.16 Million
Q3 2018

Oct 15, 2018
BUY
$98.13 - $108.9 $196 - $217
2 Added 0.0%
69,333 $7.53 Million
Q2 2018

Jul 30, 2018
BUY
$96.1 - $103.24 $19,700 - $21,164
205 Added 0.3%
69,331 $6.84 Million
Q1 2018

Apr 24, 2018
BUY
$92.16 - $103.8 $18,432 - $20,760
200 Added 0.29%
69,126 $6.77 Million
Q4 2017

Feb 02, 2018
BUY
$85.26 - $94.62 $606,710 - $673,315
7,116 Added 11.51%
68,926 $6.4 Million
Q3 2017

Oct 26, 2017
BUY
$79.29 - $88.45 $4.9 Million - $5.47 Million
61,810
61,810 $5.3 Million

Others Institutions Holding DHR

# of Institutions
2,511
Shares Held
540M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Broderick Brian C Portfolio

Follow Broderick Brian C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email